Abstract

Type I Interferon (IFN-α/β) is an innate cytokine important for fighting infections and is used to treat a variety of diseases. Here, we show that IFN-α/β plays a role in shaping the Th2 response in humans. We propose that activation of this Th2 regulatory pathway with IFN-α/β, or other antagonist with fewer side effects, will be helpful in the treatment of severe asthma and other chronic atopic diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call